[Beneficial effect of interferon alfa-2a in a case of splenic lymphoma with circulating villous cells].
Ferrer Marco
R
R
Ruiz Guinaldo
M A
MA
Martínez Martínez
J
J
Navarro Gonzalo
I
I
D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008214:Lymphocytes / Q000473:pathology; D008223:Lymphoma / Q000097:blood / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D011994:Recombinant Proteins; D013156:Splenectomy; D013160:Splenic Neoplasms / Q000097:blood / Q000473:pathology / Q000628:therapy*
D007155:Immunologic Factors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Efecto beneficioso del interferón alfa 2a en un caso de linfoma esplénico con linfocitos vellosos circulantes.